Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-07-10
2007-07-10
Zeman, Mary K. (Department: 1631)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023500, C536S024300, C536S024310, C514S04400A, C435S006120, C435S320100, C436S501000
Reexamination Certificate
active
09924400
ABSTRACT:
Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly breast cancer.
REFERENCES:
patent: 5082767 (1992-01-01), Hatfield et al.
patent: 5231012 (1993-07-01), Mosmann et al.
patent: 5428145 (1995-06-01), Okamoto et al.
patent: 5516650 (1996-05-01), Foster et al.
patent: 5523225 (1996-06-01), Kraus
patent: 5585270 (1996-12-01), Grotendorst et al.
patent: 5811535 (1998-09-01), Adamou et al.
patent: 5872237 (1999-02-01), Feder et al.
patent: 5912143 (1999-06-01), Bandman et al.
patent: 6225054 (2001-05-01), Frudakis et al.
patent: 6329505 (2001-12-01), Xu et al.
patent: 6344550 (2002-02-01), Frudakis et al.
patent: 6395278 (2002-05-01), Xu et al.
patent: 6423496 (2002-07-01), Frudakis et al.
patent: 6586570 (2003-07-01), Frudakis et al.
patent: 6620922 (2003-09-01), Xu et al.
patent: 6630305 (2003-10-01), Xu et al.
patent: 6656480 (2003-12-01), Retter et al.
patent: 6828431 (2004-12-01), Frudakis et al.
patent: 6861506 (2005-03-01), Frudakis et al.
patent: 2002/0009738 (2002-01-01), Houghton et al.
patent: 2002/0022248 (2002-02-01), Xu et al.
patent: 2002/0051977 (2002-05-01), Xu et al.
patent: 2002/0068285 (2002-06-01), Frudakis et al.
patent: 2002/0165371 (2002-11-01), Frudakis et al.
patent: 2002/0183251 (2002-12-01), Xu et al.
patent: 2002/0192763 (2002-12-01), Xu et al.
patent: 2002/0193296 (2002-12-01), Xu et al.
patent: 2003/0088062 (2003-05-01), Xu et al.
patent: 2044940 (1992-12-01), None
patent: 0475623 (1992-03-01), None
patent: 1033401 (2000-09-01), None
patent: 2 273 099 (1994-06-01), None
patent: WO 91/02062 (1991-02-01), None
patent: WO 92/10573 (1992-06-01), None
patent: WO 92/15680 (1992-09-01), None
patent: WO 94/11514 (1994-05-01), None
patent: WO 95/10777 (1995-04-01), None
patent: WO 95/19369 (1995-07-01), None
patent: WO 95/32311 (1995-11-01), None
patent: WO 96/38463 (1996-12-01), None
patent: WO 97/06256 (1997-02-01), None
patent: WO 97/06260 (1997-02-01), None
patent: WO 97/25426 (1997-07-01), None
patent: WO 97/25431 (1997-07-01), None
patent: WO 98/06399 (1998-02-01), None
patent: 98/45328 (1998-10-01), None
patent: WO 98/45328 (1998-10-01), None
patent: WO 99/06550 (1999-02-01), None
patent: WO 99/31236 (1999-06-01), None
patent: WO 00/04149 (2000-01-01), None
patent: WO 00/61753 (2000-10-01), None
patent: WO 01/25272 (2001-04-01), None
patent: WO 01/34802 (2001-05-01), None
patent: WO 01/51628 (2001-07-01), None
patent: WO 01/51633 (2001-07-01), None
patent: WO 01/75171 (2001-10-01), None
patent: WO 01/90152 (2001-11-01), None
patent: WO 03/013431 (2003-02-01), None
Genbank Accession No. AA533501, Aug. 21, 1997.
Genbank Accession No. AQ063365, Jul. 31, 1998.
Genbank Accession No. AQ124119, Sep. 22, 1998.
Genbank Accession No. AQ204617, Sep. 17 1998.
Lehninger, A. Biochemistry. 1970. Worth Publisher, Inc. NY, NY.
Nagata et al. (1999) Biochem. Biophys. Res. Commun. 261: 445-451.
Adams et al., Genbank Accession No. Q60347, 1993.
Adams et al., Genbank Accession No. Q61250, 1993.
Ahmed et al., “Characterization of retrovirus isolated form normal mink cells co-cultivated with a dog mammary tumour,”J. Gen. Virol. 42:179-184, 1979.
Anderson et al., “Sequence and organization of the human mitochondrial genome,”Nature 290:457-465, 1981.
Bakker et al., “Generation of antimelanoma cytotoxic T lymphocytes for healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vivo,”Cancer Research 55:5330-5334, Nov. 15, 1995.
Bauer et al., “Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR),”Nucleic Acids Research 21(18):4272-4280, 1993.
Bernard et al., “Cloning and Sequencing of Pro-α1(XI) Collagen cDNA Demonstrates That Type XI Belongs to the Fibrillar Class of Collagens and Reveals That the Expression of the Gene Is Not Restricted to Cartilagenous Tissue,”J. Biol. Chem. 263(32):17159-17166, 1988.
Bratthauer et al., “Expression of LINE-1 Retrotransposons in Human Breast Cancer,”Cancer 73:2333-2336, 1994.
Byrne et al., “A Screening Method to Identify Genes Commonly Overexpressed in Carcinomas and the Identification of a Novel Complementary DNA Sequence,”Cancer Research 55:2869-2903, 1995.
Cease et al., “T cell clones specific for an amphipathic α-helical region of sperm whale myoglobin show differing fine specificities for synthetic peptides,”Journal of Experimental Medicine 164:1779-1784, Nov. 1986.
Chai et al., Genbank Accession No. U03644, 1994.
Charnock-Jones et al., “Extension of incomplete cDNAs (ESTs) by biotin./streptavidin- mediated walking using polymerase chain reaction,”J. Biotechno. 35:205-215, Jun. 1994.
Chen and Sager, “Differential Expression of Human Tissue Factor in Normal Mammary Epithelial Cells and in Carcinomas,”Molecular Medicine 1(2): 153-160, 1995.
Cordonnier et al., “Isolation of Novel Human Endogenous Retrovirus-Like Elements with Foamy Virus-RelatedpolSequence,”Journal of Virology 69(9):5890-5897, 1995.
Databank Genebank Accession No. Z34289, 1995.
Derks et al., “Synthesis of a viral protein with molecular weight of 30,000 (p30) by leukemic cells and antibodies cross-reacting with simian sarcoma virus p30 in serum of a chronic myeloid leukemia patient,”Cancer Research 42:681-686, Feb. 1982.
Ezzell, “Cancer “Vaccines”: An Idea Whose Time Has Come?,”The Journal of NIH Research 7:46-49, 1995.
Frank et al., Genbank Accession No. Q70049, 1994.
Gura, “Systems for Identifying New Drugs Are Often Faulty,”Science 278:1041-1042, 1997.
Haltmeier et al., “Identification of S71-Related Human Endogenous Retroviral Sequences with Full-LengthpolGenes,”Virology 209:550-560, 1995.
Hehlmann et al., “Detection and biochemical characterization of antigens in human leukemic sera that cross-react with primate C-type viral proteins (M 30,000)1,”Cancer Research 43:392-399, Jan. 1983.
Herbrink et al., “Detection antibodies cross-reactive with type C RNA tumor viral p30 protein in human sera and exudate fluids,”Cancer Research 40:166-173, Jan. 1980.
Hillier et al., Genbank Accession No. H80165, 1995.
Hillier et al., Genbank Accession No. R19532, 1995.
Hillier et al., Genbank Accession No. R55637, 1995.
Hillier et al., Genbank Accession No. R60426, 1995.
Hillier et al., Genbank Accession No. T83348, 1995.
Hillier et al., Genbank Accession No. R35308, 1995.
Hopp, T., “Computer prediction of protein surface features and antigenic determinants,”Molecular Basis of CancerPart B: Macromolecular Recognition, Chemotherapy, and Immunology:367-377, 1985.
Jerabek et al., “Detection and immunochemical characterization of a primate type C retrovirus-related p30 protein in normal human placentas,”Proc. Natl. Acad. Sci. USA 81:6501-6505, Oct. 1984.
Kast et al., “Role of HLA-A motifs in identification of potential CTL epitopes in human papillmavirus type 16 E6 and E7 proteins,”J. Immunol.152:3904-3912, 1994.
Kawakami et al., “Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression,”J. Immunol. 154:3961-3968, 1995.
Keydar et al., “Properties of retrovirus-like particles produced by a human breast carcinoma cell line: Immunological relationship with mouse mammary tumor virus proteins,”Proc. Natl. Acad. Sci. USA81:4188-92, 1984.
Leib-Mösch and Seifarth, “Evolution and Biological Significance of Human Retroelements,”
Day Craig H.
Deng Ta
Dillon Davin C.
Frudakis Tony N.
Harlocker Susan L.
Corixa Corporation
Seed IP Law Group PLLC
Zeman Mary K.
LandOfFree
Compositions and methods for the therapy and diagnosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the therapy and diagnosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the therapy and diagnosis of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3809116